Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-01-09 @ 9:48 PM
Study NCT ID:
NCT02354105
Status:
COMPLETED
Last Update Posted:
2019-03-11
First Post:
2015-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
Sponsor:
UCB Biopharma S.P.R.L.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-29
First Submit QC Date:
None
Study First Post Date:
2015-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-08
Last Update Post Date:
2019-03-11
Last Update Post Date Type:
ACTUAL